The drug armoury for multiple sclerosis (MS) is ever-expanding. This topic has been extensively covered by our sister blog, The Neurology Lounge, in the blog posts titled Which are the remarkable drugs which have transformed the treatment of MS, Multiple sclerosis treatment: new kids on the block, The emerging progress from the world of MS, and How good is ocrelizumab for primary progressive MS.
This blog post lists all the current MS disease modifying therapies (DMTs), with links to their Neurochecklist page. Each checklist gives a comprehensive summary of mode of action, dosing, side effects, monitoring indices, and precautions. Here they are:
DMTs for mild disease
DMTs for aggressive disease
Second line DMTs for aggressive disease
Because the work is never done with MS, we also list the emerging DMTs that will shape MS practice in the near future.